493 Shares in HCA Healthcare, Inc. (NYSE:HCA) Purchased by Resonant Capital Advisors LLC

Resonant Capital Advisors LLC bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 493 shares of the company’s stock, valued at approximately $200,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Bangor Savings Bank boosted its position in shares of HCA Healthcare by 112.5% during the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after acquiring an additional 45 shares during the last quarter. MFA Wealth Advisors LLC bought a new stake in shares of HCA Healthcare in the 2nd quarter worth about $27,000. Unique Wealth Strategies LLC purchased a new position in HCA Healthcare in the second quarter worth about $28,000. GPS Wealth Strategies Group LLC raised its position in HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after purchasing an additional 71 shares during the period. Finally, Benjamin F. Edwards & Company Inc. bought a new position in shares of HCA Healthcare during the 2nd quarter valued at approximately $33,000. Institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently issued reports on HCA. Oppenheimer raised their target price on shares of HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. Cantor Fitzgerald reissued an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a research note on Tuesday, October 1st. Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. UBS Group boosted their price objective on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research report on Wednesday, August 14th. Finally, StockNews.com raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Monday, July 1st. Five analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and four have given a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $365.65.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the transaction, the senior vice president now owns 40,449 shares in the company, valued at approximately $14,569,729.80. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 17,202 shares of company stock valued at $6,407,273 in the last three months. 1.60% of the stock is owned by insiders.

HCA Healthcare Stock Down 1.1 %

Shares of HCA Healthcare stock opened at $410.77 on Tuesday. The firm’s 50 day moving average price is $393.16 and its 200-day moving average price is $351.09. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $417.14. The company has a market cap of $107.59 billion, a P/E ratio of 20.48, a PEG ratio of 1.44 and a beta of 1.67.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, topping the consensus estimate of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The firm had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. During the same period in the previous year, the business earned $4.29 EPS. The firm’s revenue for the quarter was up 10.3% on a year-over-year basis. On average, sell-side analysts predict that HCA Healthcare, Inc. will post 22.51 EPS for the current fiscal year.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.